Correlation Between Crispr Therapeutics and 89bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Crispr Therapeutics and 89bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crispr Therapeutics and 89bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crispr Therapeutics AG and 89bio Inc, you can compare the effects of market volatilities on Crispr Therapeutics and 89bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crispr Therapeutics with a short position of 89bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crispr Therapeutics and 89bio.

Diversification Opportunities for Crispr Therapeutics and 89bio

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between Crispr and 89bio is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and 89bio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 89bio Inc and Crispr Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crispr Therapeutics AG are associated (or correlated) with 89bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 89bio Inc has no effect on the direction of Crispr Therapeutics i.e., Crispr Therapeutics and 89bio go up and down completely randomly.

Pair Corralation between Crispr Therapeutics and 89bio

Given the investment horizon of 90 days Crispr Therapeutics AG is expected to generate 0.7 times more return on investment than 89bio. However, Crispr Therapeutics AG is 1.42 times less risky than 89bio. It trades about 0.03 of its potential returns per unit of risk. 89bio Inc is currently generating about 0.0 per unit of risk. If you would invest  5,076  in Crispr Therapeutics AG on September 2, 2024 and sell it today you would earn a total of  41.00  from holding Crispr Therapeutics AG or generate 0.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Crispr Therapeutics AG  vs.  89bio Inc

 Performance 
       Timeline  
Crispr Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Crispr Therapeutics AG are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Crispr Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
89bio Inc 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in 89bio Inc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, 89bio may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Crispr Therapeutics and 89bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Crispr Therapeutics and 89bio

The main advantage of trading using opposite Crispr Therapeutics and 89bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crispr Therapeutics position performs unexpectedly, 89bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 89bio will offset losses from the drop in 89bio's long position.
The idea behind Crispr Therapeutics AG and 89bio Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Money Managers
Screen money managers from public funds and ETFs managed around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas